Medicare Advantage updates while halting proposed anti-obesity drug coverage, impacting millions of potential beneficiaries.

On World Health Day,a 31 country Ipsos Health Service Report 2024 showsthe health concernsbothering Indians most were ...

Advances recognized by science’s most lucrative awards include high-energy physics experiments and groundbreaking weight-loss ...

Study results in a rare form of obesity could help the company expand use of Imcivree, which is approved for two genetically ...

Stifel analysts were bullish on the data, which showed a 16.5% drop in body-mass index among patients with damage to the ...

While pharma giants Novo Nordisk and Eli Lilly may have a solid hold on the obesity arena, Rhythm Pharmaceuticals is looking ...

The growing number of Australians with obesity is causing economic damage but should the taxpayer fund weight-loss drugs?

A popular weight-loss drug used by celebrities overseas has been approved by New Zealand’s medicine regulatory body, with its ...

Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

Germany's largest pharmaceutical company Boehringer Ingelheim on Wednesday reported a currency-adjusted 6.1% gain in 2024 ...

Investing.com -- Shares of Zealand Pharma (CSE: ZELA) fell on Tuesday following the release of interim topline results from Gubra’s (CSE: GUBRA) multiple ascending dose (MAD) study of its ...

Lexicon Pharmaceuticals Inc. said March 28 it will exclusively license its drug candidate LX9851 to Danish pharmaceutical ...